Phencyclidine in the social interaction test: an animal model of schizophrenia with face and predictive validity
by
Sams-Dodd F
Pharmacological Research,
H. Lundbeck A/S, Valby, Denmark.
Rev Neurosci 1999; 10(1): 59-90


ABSTRACT

Phencyclidine (PCP) is a hallucinogenic drug that can mimic several aspects of the schizophrenic symptomatology in healthy volunteers. In a series of studies PCP was administered to rats to determine whether it was possible to develop an animal model of the positive and negative symptoms of schizophrenia. The rats were tested in the social interaction test and it was found that PCP dose-dependently induces stereotyped behaviour and social withdrawal, which may correspond to certain aspects of the positive and negative symptoms, respectively. The effects of PCP could be reduced selectively by antipsychotic drug treatment, whereas drugs lacking antipsychotic effects did not alleviate the PCP-induced behaviours. Together these findings indicate that PCP effects in the rat social interaction test may be a model of the positive and negative symptoms of schizophrenia with face and predictive validity and that it may be useful for the evaluation of novel antipsychotic compounds.
PCP
Ketamine
Glutamate
Memantine
Neuroprotectants
NMDA antagonists
Glutamate and GABA
Phencyclidine: structure
Schizoaffective disorder
Schizophrenia: new drugs
Schizophrenia: neuroleptics
NMDA-receptor antagonists
Serotonin hypothesis of schizophrenia
Dopamine hypothesis of schizophrenia


Refs
and further reading

HOME
HedWeb
Nootropics
erythroxylum-coca.com
Future Opioids
BLTC Research
MDMA/Ecstasy
Superhapiness?
Utopian Surgery?
The Abolitionist Project
The Hedonistic Imperative
The Reproductive Revolution
Critique of Huxley's Brave New World

The Good Drug Guide
The Good Drug Guide

The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family